期刊文献+

胃癌中cyr-61、cox-2的表达及其临床病理学意义 被引量:7

Expression of cyr-61 and cox-2 in Gastric Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 目的检测胃癌组织及非瘤胃黏膜组织中富含半胱氨酸61蛋白(cyr-61)和环氧合酶2蛋白(cox-2)的表达水平,探讨二者表达的临床病理意义。方法应用免疫组织化学方法(S-P法)检测82例胃癌组织及43例非瘤胃黏膜组织中cyr-61、cox-2蛋白的表达。结果 82例胃癌中cyr-61蛋白高表达率为60.98%(50/82),非瘤胃黏膜组织中cyr-61蛋白的高表达率为34.88%(15/43),两者间差异有统计学意义(P<0.01);胃癌组织中cox-2的高表达率为62.20%(51/82),非瘤胃黏膜组织中cox-2高表达率为41.86%(18/43),差异亦有统计学意义(P<0.05)。其中胃癌淋巴结转移组cyr-61蛋白及cox-2蛋白高表达率均显著高于无淋巴结转移组(P<0.001);远距离转移组中cyr-61蛋白及cox-2蛋白高表达率均显著高于无远距离转移组(P<0.05);55例完整随访资料显示,cyr-61蛋白及cox-2蛋白高表达组5年生存率均显著低于低表达组5年生存率(P<0.001);cyr-61蛋白与cox-2蛋白在胃癌组织中的表达水平呈正相关关系(χ2=6.56,P<0.05)。结论 cyr-61、cox-2蛋白在胃癌组织中呈高表达,且表达水平与淋巴结转移、远距离转移、5年生存率密切相关,cyr-61、cox-2蛋白有可能成为胃癌预后的重要指标之一。 Objective To investigate the expression and the clinical significance of Cysteine-rich 61(Cyr-61/CCN1)and Cyclooxygenase-2(cox-2) in human gastric carcinoma.Methods The expression level of cyr-61 and cox-2 in 82 human gastric carcinoma and 43 non-tumor gastric mucosa tissues were detected by immunohistochemical staining.Results In the 82 gastric cancer,the incidence of high cyr-61 expression was 60.98%(50/82),in contrast,the incidence in 43 non-tumor gastric mucosa tissues was 34.88%(15/43),(P 〈 0.01);The rate of high cox-2 expression was 62.20 %(51/82) in gastric cancer,in contrast,41.86%(18/43) in non-tumor gastric mucosa tissues.(P 〈 0.05).In gastric cancer with lymph node metastasis,the incidence of high cyr-61 and cox-2 expression were both significantly higher than that of gastric cancer without lymph node metastasis(P 〈 0.001).In gastric cancer with distance metastasis the incidence of high cyr-61 and cox-2 expression were both significantly higher than that of gastric cancer without distance metastasis,(P 〈 0.05).55 complete data shown that in patients with high cyr-61,cox-2 expression,the 5-year overall survival rate were both significantly lower than that of low cyr-61,cox-2 expression patients,(P 〈 0.001).The expression of cyr-61 was positive correlation with the expression of cox-2 in gastric cancer,(χ2 =6.56,P 〈 0.05).Conclusion In gastric carcinoma,the expression of cyr-61 and cox-2 was high compare to non-tumor gastric mucosa tissues,and in patients with gastric cancer the expression level of cyr-61 and cox-2 was correlation with lymph node metastasis,distance metastasis,5-year overall survival rate.cyr-61 might be a prognosis marker for gastric carcinoma.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2011年第8期744-748,共5页 Journal of China Medical University
关键词 胃癌 eyr-61 COX-2 gasuic carcinoma cyr-61 cox-2
  • 相关文献

参考文献1

二级参考文献14

  • 1崔玲玲,孙锦峰,王旗,赵松,赵高峰,秦建军,陈萍萍,李文杰,谢东.肺癌组织中Cyr61基因表达及临床意义[J].肿瘤,2007,27(4):286-289. 被引量:9
  • 2Tong X, O'KeUyJ, Xie D, et al. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway. Oncogene, 2004, 23(28): 4847-4855.
  • 3Hao XP, Willis JE, Pretlow TG, et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res, 2000, 60 (1): 18-21.
  • 4Holloway SE, Beck AW, Girard L, et al. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J Am Coil Surg, 2005, 200(3): 371-377.
  • 5Gery S, Xie D, Yin D, et al. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Cancer Res, 2005, 11 (20): 7243-7254.
  • 6Tong X, Xie D, O'KeUyJ, et al. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem, 2001, 276(50): 47709-47714.
  • 7Kleer CG, Zhang Y,, Pan Q, et al. WISP3 and Rhoc guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Res, 2004, 6(2): R110-R115.
  • 8Kleer CG, Zhang Y, Pan q et al. WISP-3 (CCN6) is secreted tumoursuppressor protein that IGF signaling in inflammatory breast cancer. Neoplasia, 2004, 6(2): 179-185.
  • 9Thorstensen L, Diep CB, Meling GT, et al. WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas as with microsatellite instability. Castroentemlogy, 2001- 121(6): 1275-1280.
  • 10Gervello M, Giannitmpani L, Labbozzetta M, et al. Expression of WISP3 and of their novel alternative variants in human hepatocellular carcinoma cells. Ann NYAcad Sci, 2004, 1028(3): 432-439.

共引文献6

同被引文献62

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部